HDS Insights Arena
KI Innovations InvestorDay
Monthly Perspective: Accelerating health innovation from the West
CECILIA EDEBO: It’s been just over a year since I stepped into the role of CEO at Sahlgrenska Science Park – and what an inspiring, eventful year it has been. I’ve had the privilege of working alongside passionate innovators, dedicated researchers, healthcare professionals, forward-thinking entrepreneurs and a thriving life science ecosystem that is committed to addressing global health challenges by unleashing the power of co-action.
From Lab to Market – Navigating the Path to Success in Cell and Gene Therapy
Cell and gene therapies are being introduced into healthcare at an increasing rate. Developments in this field show great promise for curing previously untreatable diseases.
KI Science Park Lunch Talks
The move to Hagastaden made Atlas Antibodies even stronger
Atlas Antibodies specializes in the development and production of high-quality antibodies for research. Their product range covers the entire proteome, with a particular focus on cancer, immunology, and neurology. Since a year, they are based in Hagastaden to make the most of this dynamic ecosystem.